BROOKE ESTEVES
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology HANCOCK, MI NPI 1265726970
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology MI Alafair Biosciences, Inc. All categories
General Payments — all program years on this page
$1,824.06
- Category: General Payments
- Program years: PY2018–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $935.40 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $935.40 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Alafair Biosciences, Inc. | $153.64 | 1 |
| Alexion Pharmaceuticals, Inc. | $128.15 | 1 |
| Janssen Biotech, Inc. | $125.90 | 1 |
| EISAI INC. | $125.00 | 1 |
| GlaxoSmithKline, LLC. | $107.27 | 1 |
| Fennec Pharmaceuticals, Inc. | $103.08 | 1 |
| E.R. Squibb & Sons, L.L.C. | $96.25 | 1 |
| Gilead Sciences, Inc. | $96.11 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078750232 | Janssen Biotech, Inc. | $125.90 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1093961844 | Alexion Pharmaceuticals, Inc. | $128.15 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101345527 | E.R. Squibb & Sons, L.L.C. | $96.25 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110734935 | Eisai Inc. | $125.00 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116273594 | GlaxoSmithKline, LLC. | $107.27 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120185510 | Fennec Pharmaceuticals, Inc. | $103.08 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133643494 | Gilead Sciences, Inc. | $96.11 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1138673822 | Alafair Biosciences, Inc. | $153.64 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.